Browse by Medical Category
Accepting New Patients
Go To Programs
Go To Programs
Go To Specialties
Barbara L. Smith, MD, PhD. is the Director of the Breast Program and Co-Director of the Women's Cancers Program at Massachusetts General Hospital. She is an Associate Professor of Surgery at Harvard Medical School and at the MGH. Dr. Smith received her undergraduate training at Massachusetts Institute of Technology, an MD. from Harvard Medical School's Harvard/MIT Division of Health Sciences and Technology and a PhD from Harvard University Graduate School of Arts and Sciences. Dr. Smith's research activities have focused on reducing the extent of surgery and radiation required to treat breast cancer, diagnosis and treatment issues in young women with breast cancer, and three dimensional breast anatomy as it relates to breast surgery and pathologic analysis of specimens. She has been a Visiting Professor at Sun Yat-sen University in China since 2006 where she has assisted in development of multidisciplinary breast cancer programs and clinical research activities. Dr. Smith was named one of Boston Magazine's Top Docs for 2013 for Breast Cancer.
Nipple sparing mastectomy
High risk patients
View my most recent publications at PubMed
Nipple-sparing mastectomy. Rusby JE, Smith BL, Gui GP. Br J Surg 2010 Mar;97(3);305-16.
An inferolateral approach to nipple-sparing mastectomy: optimizing mastectomy and reconstruction. Colwell AS, Gadd M, Smith BL, Austen WG Jr. Ann Plast Surg. 2010 Aug;65(2):140-3.
Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens. Brachte EF, Rusby Je, Michaelson JS, Chen LL, Muzikansky A, Smith BL, Koerner FC. J Clin Oncol 2009 Oct 20;27(30):4930-2
Development and validation of a model predictive of occult nipple involvement in women undergoing mastectomy. Rusby JE, Bracte EF, Othus M, Michaelson JS, Koerner FC, Smith, BL Br J Surg: 2008 Nov;95(11):1356-61
A new MGH study is one of the first to detail the outcomes of breast reconstruction surgery after having a nipple-sparing mastectomy, and this new, hard data, researchers say, is good news.
The Vaccine and Immunotherapy Center at Mass General focuses on locating the most promising research and safely accelerating its transformation into new lifesaving products.
Back to Top